AbbVie Inc/ US00287Y1091 /
| 8/8/2022 9:59:58 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 140.38USD | - | 129,906 Turnover: 18.11 mill. |
-Bid Size: - | -Ask Size: - | 248.13 bill.USD | 3.78% | 21.66 |
Fundamentals
| FY 2021 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 6.48 USD | 137.36% |
| EPS Diluted: | 6.45 USD | 137.13% |
| Revenues per Share: | 31.75 USD | 15.55% |
| Book Value per Share: | 8.72 USD | 11.00% |
| Cash Flow per Share: | 12.87 USD | 21.97% |
| Dividend per Share: | 5.31 USD | 9.71% |
| Total | in mill. | |
| Revenues: | 56,197.00 USD | 22.69% |
| Net Income: | 11,542.00 USD | 150.04% |
| Operating Cash Flow: | 22,777.00 USD | - |
| Cash and Cash Equivalents: | 9,746.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 21.66 | 20.90 |
| P/S Ratio: | 4.42 | 4.26 |
| P/BV ratio: | 16.09 | 15.53 |
| P/CF Ratio: | 10.91 | 10.52 |
| PEG: | 0.16 | 0.15 |
| Earnings Yield: | 4.62% | 4.79% |
| Dividend Yield: | 3.78% | 3.92% |
| Market Capitalization | ||
| Market Capitalization: | 248.13 bill. USD | 239.66 bill. USD |
| Free Float Market Cap.: | 209.48 bill. USD | 202.32 bill. USD |
| Market Cap. / Employee: | 4.97 mill. USD | 4.79 mill. USD |
| Shares Outstanding: | 1.77 bill. | |
Profitability
| Gross Profit Margin: | 100.00% |
| EBIT Margin: | 31.89% |
| Net Profit Margin: | 20.54% |
| Return on Equity: | 74.77% |
| Return on Assets: | 7.88% |
Financial Strength
| Liquidity I / Cash Ratio: | 27.69% |
| Liquidity II / Quick Ratio: | 27.69% |
| Liquidity III / Current Ratio: | 79.35% |
| Debt / Equity Ratio: | 849.27% |
| Dynam. Debt / Equity Ratio: | 575.55% |
Efficiency
| Employees: | 50,000 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | 1,123,940.00 USD |
| Net Income / Employee: | 230,840.00 USD |
| Total Assets / Employee: | 2,930,580.00 USD |
| * Fiscal Year End: | 12/31/2021 |
| Accounting Standard: | US GAAP |
| Currency: | USD |